Galderma Group AG - Unsponsored ADR (GALDY)
(Delayed Data from OTC)
$32.15 USD
+0.50 (1.58%)
Updated Aug 7, 2025 03:36 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
GALDY 32.15 +0.50(1.58%)
Will GALDY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GALDY based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for GALDY
Bayer Stock Is Soaring Ahead Of Its Earnings Release
Galderma price target raised by CHF 52.30 at Berenberg
Galderma price target raised by CHF 14 at RBC Capital
Galderma price target raised by CHF 40 at JPMorgan
Galderma price target raised by CHF 35 at Citi